FDAapproved

SAN DIEGO, July 05, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reaffirmed its commitment to the commercial launch of XACIATO (clindamycin phosphate) vaginal gel, 2% with…

EATONTOWN, N.J. and ORLANDO, Fla., June 13, 2023 (GLOBE NEWSWIRE) -- Avertix Medical, Inc. (“Avertix” or the “Company”), formerly known as Angel Medical Systems, Inc., a company focused on improving long-term management and outcomes of…

For the first time, researchers described the structure of a special type of amyloid beta plaque protein associated with Alzheimer's disease (AD) progression. In a report published May 10 in the journal Neuron, scientists showed the small…

Findings from a Johns Hopkins Children's Center study in animal models show that a U.S. Food and Drug Administration (FDA)-approved antibiotic regimen for multidrug-resistant (MDR) tuberculosis (TB) may not work for TB meningitis. Studies…

Cara Murez FRIDAY, Dec. 9, 2022 (HealthDay News) -- Owners whose cats have diabetes now have a new option to care for the condition in their otherwise healthy pets.The U.S. Food and Drug Administration…

Physician’s Briefing Staff THURSDAY, Dec. 1, 2022 (HealthDay News) -- The U.S. Food and Drug Administration on Wednesday approved the first fecal microbiota treatment, aimed at helping adults battling…

GAITHERSBURG, Md., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has completed its acquisition of exclusive worldwide rights to TEMBEXA® (brincidofovir), the first oral antiviral…

UT Southwestern researchers have identified a molecular pathway responsible for the spread of glioblastoma to surrounding tissue in the brain, as well as an existing drug that curbed tumor growth in animal models. The findings, published in…

Indiana University School of Medicine researchers found that niacin limits Alzheimer's disease progression when used in models in the lab, a discovery that could potentially pave the way toward therapeutic approaches to the disease. The…

Several FDA-approved drugs -- including for type 2 diabetes, hepatitis C and HIV -- significantly reduce the ability of the Delta variant of SARS-CoV-2 to replicate in human cells, according to new research led by scientists at Penn State.…